Ivarmacitinib, a selective oral Janus kinase 1 inhibitor, significantly improved signs and symptoms in patients with moderate to severe atopic dermatitis (AD) and showed a favorable safety profile ...

A panelist discusses how the evolving landscape of atopic dermatitis treatment is moving toward a more personalized approach that carefully balances efficacy goals with safety considerations, ...

Raelle Kennedy spent years managing the skin manifestations of her eczema. Topical steroid withdrawal urged her to get at the ...

The atopic dermatitis app will launch first in the UK, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later in 2022. Image Phil Taylor ...

What I Wish I Knew Sooner About How People Really View My Eczema What I Wish I Knew About the Victim-Blaming I’d Face by Scratching My Atopic Dermatitis What I Wish I Knew About Atopic ...

The approval comes at a critical time: approximately 6% of adolescents within this newly approved age group suffer from atopic dermatitis in the UK. In other words, one in five children.

Mona Shahriari, MD, discusses how RAD 2025 can equip providers with tools to improve atopic dermatitis outcomes. As dermatologic science continues to evolve, the Revolutionizing Atopic Dermatitis (RAD ...

Early-onset atopic dermatitis in pediatric patients may warrant referral to ophthalmology for uveitis evaluation. The researchers pulled health records from patients with early onset AD (before age 2) ...

Jennifer Etienne was worried her severe atopic dermatitis would prevent her from landing roles. Did her rough skin stop her from shining on screen?